Anika Therapeutics, Inc. (ANIK)
Company Info
Highlights
$161.20M
-$0.75
1.91
$105.55M
$66.05M
$633.00K
$10.89 - $29.12
$21.33
3.34%
5.98
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Anika Therapeutics, Inc. (ANIK) returned -32.26% year-to-date (YTD) and -56.63% over the past 12 months. Over the past 10 years, ANIK returned -10.32% annually, underperforming the S&P 500 benchmark at 10.85%.
ANIK
-32.26%
-23.26%
-37.08%
-56.63%
-19.95%
-19.76%
-10.32%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of ANIK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3.65% | 2.29% | -13.87% | -3.33% | -23.26% | -32.26% | |||||||
| 2024 | 3.80% | 3.23% | 4.61% | 1.93% | -0.93% | -1.25% | 7.58% | -5.69% | -3.89% | -30.73% | 3.57% | -7.11% | -27.36% |
| 2023 | 4.76% | 2.23% | -9.40% | -10.65% | 5.57% | -4.10% | -10.20% | -23.49% | 4.37% | 4.67% | 12.36% | 3.42% | -23.45% |
| 2022 | -11.25% | 2.20% | -22.74% | -14.26% | 0.98% | 2.67% | 4.66% | -3.25% | 5.31% | 19.41% | 10.98% | -6.15% | -17.39% |
| 2021 | -18.23% | -0.84% | 11.14% | -1.50% | 16.10% | -7.20% | -7.30% | 7.48% | -1.32% | -2.14% | -6.05% | -8.43% | -20.84% |
| 2020 | -20.71% | 1.58% | -30.77% | 14.94% | 0.90% | 12.53% | -3.53% | 5.30% | -7.67% | -7.83% | 15.88% | 19.74% | -12.71% |
| 2019 | 13.03% | -14.11% | -7.32% | 5.32% | 19.31% | 6.89% | 35.62% | 3.03% | -3.29% | 28.24% | -17.89% | -10.29% | 54.27% |
| 2018 | 23.76% | -21.99% | -4.48% | -11.48% | -7.61% | -21.30% | 25.09% | 3.40% | 1.91% | -15.22% | -3.66% | -2.44% | -37.66% |
| 2017 | 3.23% | -7.42% | -7.16% | 6.19% | 0.30% | 6.63% | 3.69% | 4.96% | 8.01% | -5.81% | 0.90% | -2.20% | 10.11% |
| 2016 | -1.42% | 19.96% | -0.91% | 2.10% | 3.64% | 13.38% | -6.95% | -5.37% | 1.29% | -7.29% | 5.18% | 4.93% | 28.30% |
| 2015 | -3.83% | 1.89% | 3.13% | -17.12% | -1.14% | -2.08% | 14.74% | -6.57% | -10.11% | 21.02% | 8.93% | -9.06% | -6.33% |
| 2014 | -12.81% | 18.33% | 4.39% | 3.99% | 9.57% | -1.07% | -9.22% | -0.14% | -12.71% | 9.49% | 1.87% | -0.37% | 6.76% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ANIK is 5, meaning it’s performing worse than 95% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Anika Therapeutics, Inc. (ANIK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Anika Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Anika Therapeutics, Inc. was 95.88%, occurring on Dec 26, 2000. Recovery took 1642 trading sessions.
The current Anika Therapeutics, Inc. drawdown is 84.80%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.88% | Jul 15, 1998 | 620 | Dec 26, 2000 | 1642 | Jul 25, 2007 | 2262 |
| -86.24% | Sep 24, 2007 | 321 | Dec 30, 2008 | 1154 | Aug 1, 2013 | 1475 |
| -84.84% | Oct 28, 2019 | 1403 | May 28, 2025 | — | — | — |
| -68.42% | May 13, 1993 | 395 | Dec 16, 1994 | 336 | May 3, 1996 | 731 |
| -57.96% | Jan 30, 2018 | 99 | Jun 20, 2018 | 340 | Oct 25, 2019 | 439 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Anika Therapeutics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Anika Therapeutics, Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -166.7%.
Valuation
The Valuation section provides an overview of how Anika Therapeutics, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ANIK compared to other companies in the Medical Devices industry. ANIK currently has a PEG ratio of 1.9. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ANIK relative to other companies in the Medical Devices industry. Currently, ANIK has a P/S ratio of 1.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ANIK in comparison with other companies in the Medical Devices industry. Currently, ANIK has a P/B value of 1.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |